Evidence map›Paper›PMID 34590606›Full record

ArticleCurrent oncology (Toronto, Ont.)2021

Report from the 21st Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Calgary, Alberta; 20-21 September 2019.

Richard Lee-Ying, Osama Ahmed, Shahid Ahmed, Shahida Ahmed, Oliver F Bathe, Bryan Brunet, Laura Dawson, Janine Davies, Valerie Gordon, Pamela Hebbard and 14 more

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Richard Lee-YingTom Baker Cancer Center, Alberta Health Service, Calgary, AB T2N 4N2, Canada.
Osama AhmedSaskatoon Cancer Center, Saskatchewan Cancer Agency, Saskatoon, SK S7N 4H4, Canada.ORCID 0000-0001-9241-7695
Shahid AhmedSaskatoon Cancer Center, Saskatchewan Cancer Agency, Saskatoon, SK S7N 4H4, Canada.ORCID 0000-0002-2099-698X
Shahida AhmedDepartment of Oncology, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada.
Oliver F BatheSurgical Oncology, Arnie Charbonneau Cancer Institute, Calgary, AB T2N 4Z6, Canada.
Bryan BrunetSaskatoon Cancer Center, Saskatchewan Cancer Agency, Saskatoon, SK S7N 4H4, Canada.
Laura DawsonPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C1, Canada.
Janine DaviesDepartment of Oncology, British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada.ORCID 0000-0003-3834-6835
Valerie GordonDepartment of Oncology, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada.
Pamela HebbardDepartment of Oncology, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada.
Jessica KasnikCross Cancer Institute, Alberta Health Services, Edmonton, AB T5G 1Z2, Canada.
Christina A KimDepartment of Oncology, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada.ORCID 0000-0003-3847-2583
Duc LeSaskatoon Cancer Center, Saskatchewan Cancer Agency, Saskatoon, SK S7N 4H4, Canada.
Michael K C LeeDepartment of Oncology, British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada.ORCID 0000-0001-8075-3608
Howard LimDepartment of Oncology, British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada.
John Paul McGhieDepartment of Oncology, British Columbia Cancer Agency, Victoria, BC V8R 4S1, Canada.
Karen MulderCross Cancer Institute, Alberta Health Services, Edmonton, AB T5G 1Z2, Canada.
Jason ParkDepartment of Oncology, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada.
Daniel RenoufDepartment of Oncology, British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada.
Vincent TamTom Baker Cancer Center, Alberta Health Service, Calgary, AB T2N 4N2, Canada.
Robin VisserDepartment of Surgery, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.
Ralph P W WongDepartment of Oncology, Cancer Care Manitoba, Winnipeg, MB R3E 0V9, Canada.
Adnan ZaidiSaskatoon Cancer Center, Saskatchewan Cancer Agency, Saskatoon, SK S7N 4H4, Canada.
Corinne DollTom Baker Cancer Center, Alberta Health Service, Calgary, AB T2N 4N2, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 21st annual Western Canadian Gastrointestinal Cancer Consensus Conference (WCGCCC) was held in Calgary, Alberta, 20-21 September 2019. The WCGCCC is an interactive multi-disciplinary conference attended by health care professionals from across Western Canada (British Columbia, Alberta, Saskatchewan, and Manitoba) involved in the care of patients with gastrointestinal cancer. Surgical, medical, and radiation oncologists, pathologists, radiologists, and allied health care professionals such as dietitians and nurses participated in presentation and discussion sessions to develop the recommendations presented here. This consensus statement addresses current issues in the management of hepato-pancreato-biliary (HPB) cancers.

Indexed as

Gastrointestinal NeoplasmsAlbertaConsensusHumansManitobaSaskatchewanadjuvant chemotherapybiliary tract cancercholangiocarcinomahepatocellular carcinomapancreatic cancerstereotactic body radiation therapysurgery

Identifiers

PMID34590606
PMCPMC8482207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.